March Biosciences Secures $28.4M Series A to Advance Therapy for T-Cell Lymphoma
By Daniella Parra March Biosciences has closed an oversubscribed $28.4 million Series A financing, led...
MOBILion Systems Redefines Complex Sample Analysis
By Karen Roman MOBILion Systems, Inc. revealed its hi-res mass spectrometry functionality with implementations for...
CMR Surgical Receives FDA OK for Robot “Versius”
By Karen Roman Global surgical robotics company CMR Surgical said the FDA has granted marketing...
Jack Truong: Why Difficult Decisions Are Often the Most Necessary Decisions
Jack Truong, known for spearheading a series of high-profit corporate makeovers, reveals why taking an...
SkylineDx to Present Data on Screening for Melanoma Patients
By Karen Roman Diagnostics company SkylineDx said it will present clinical data on the success...
Enterprise TruRisk Management: Fireside with Sumedh Thakar, President & CEO of Qualys
Tech Edge hosted a fireside chat with Qualys, Inc. (Nasdaq: QLYS) to discuss the company’s...
Recordati Acquires Rights to Enjaymo from Sanofi for $825 Million
By Daniella Parra Recordati said it will acquire the global rights to Enjaymo, used to...
Duckhorn Acquired by Butterfly Equity at $1.95 Billion
By Karen Roman Winemaker The Duckhorn Portfolio, Inc. (NYSE: NAPA) said it will be taken...
Eliem Therapeutics Changes Name to Climb Bio
By Karen Roman Eliem Therapeutics, Inc. (Nasdaq: ELYM) said its new corporate name will be...
John McEntee’s @daterightstuff TikTok Provides A Window Into The Future of Political Communications, Business Development
Republicans’ attempt to ban TikTok is a ‘self-own,’ says the former Trump staffer, whose TikTok...
© Copyright 2025, ExecEdge